Safety Summary

• Predictable and manageable side effect profile

First-line combination CPT-11/5-FU/LV

• Similar incidence of grade 4 diarrhea relative to 5-FU/LV

• Low rates of grade 3/4 vomiting, mucositis, neutropenia, and febrile neutropenia

Previous slide

Next slide

Back to first slide

View graphic version